Denali Therapeutics, Inc.

Denali Therapeutics
Project Name 
Alaska
Date Announced 
April 2021
Site 
Salt Lake City
Competition 
Various Western states
“After consideration of multiple locations for expanding our footprint, we decided that Utah offers the best overall environment and we look forward to being part of the growing life science community there.”
Decision Drivers 
Strength of life sciences industry, talent, incentive value
Jobs 

100

Investment 

$40 million

Square Footage 

40,000

Incentives 

The GOED Board has approved a post-performance tax credit not to exceed $1,355,894.

Case Study Story